

[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI
[ Thu, Dec 09th 2021
] - WOPRAI

[ Wed, Dec 08th 2021
] - WOPRAI
[ Wed, Dec 08th 2021
] - WOPRAI
[ Wed, Dec 08th 2021
] - WOPRAI
[ Wed, Dec 08th 2021
] - WOPRAI
[ Wed, Dec 08th 2021
] - WOPRAI
[ Wed, Dec 08th 2021
] - WOPRAI
[ Wed, Dec 08th 2021
] - WOPRAI
[ Wed, Dec 08th 2021
] - WOPRAI
[ Wed, Dec 08th 2021
] - WOPRAI
Salveen Richter Maintained (ACAD) at Hold with Increased Target to $28 on, Dec 8th, 2021
Salveen Richter of Goldman Sachs, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Hold with Increased Target from $25 to $28 on, Dec 8th, 2021.
Salveen has made no other calls on ACAD in the last 4 months.
There are 6 other peers that have a rating on ACAD. Out of the 6 peers that are also analyzing ACAD, 4 agree with Salveen's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jay Olson of "Oppenheimer" Maintained at Hold with Increased Target to $23 on, Tuesday, December 7th, 2021
- Jeffrey Hung of "Morgan Stanley" Maintained at Hold with Increased Target to $24 on, Tuesday, December 7th, 2021
- Neena Bitritto-Garg of "Citigroup" Maintained at Hold with Increased Target to $28 on, Tuesday, December 7th, 2021
- Vamil Divan of "Mizuho" Maintained at Hold with Increased Target to $26 on, Tuesday, December 7th, 2021
These are the ratings of the 2 analyists that currently disagree with Salveen
- Jason Butler of "JMP Securities" Maintained at Buy with Increased Target to $39 on, Tuesday, December 7th, 2021
- Yatin Suneja of "Guggenheim" Upgraded from Hold to Strong Buy and Held Target at $23 on, Monday, November 1st, 2021
Contributing Sources